Amniotic Membrane #1
Amniotic Membrane #1 is a dehydrated amniotic/chorionic/amniotic membrane sheet designed to aid in wound management. It is composed of three layers: amnion, chorion, and amnion, providing enhanced rigidity and flexibility.
Key Features:
-
Protective Covering: Provides a protective barrier for wound management.
-
Non-Specific Orientation: Can be applied in any orientation, making it easy to position and reposition.
-
Tensile Strength: Enhanced tensile strength ensures adherence and easy application.
-
Versatility: Can be used in both hydrated and dehydrated states.
Clinical Efficacy:
Amniotic Membrane #1 is intended for the repair, reconstruction, replacement, or supplementation of injured tissue. It retains important structural proteins and ECM biochemicals naturally present in placental tissue, promoting healing and regeneration. Research indicates the use of amniotic membrane derivatives like Amniotic Membrane #1 has a high success rate, with 86% to 90% efficacy in treating chronic wounds​​.
Amniotic Membrane #2
Amniotic Membrane #2 is a dual-layer, dehydrated human amnion membrane allograft derived from the amniotic lining of the placenta. It is chorion-free and processed using minimally manipulated techniques to retain the native extracellular matrix (ECM) qualities. The graft is designed to provide a protective barrier for soft tissue wounds.
Key Features:
-
Quality and Safety: Processed in accordance with FDA regulations and AATB standards. The amniotic tissue is recovered from healthy mothers post full-term delivery.
-
Storage and Application: Requires no up-front preparation and can be stored at ambient temperatures. It can be applied on either side of the graft and quickly hydrates in situ.
-
Sterilization: E-Beam sterilization provides a sterility assurance level (SAL) of 10-6.
Clinical Efficacy: Amniotic Membrane #2 has been documented to protect diabetic ulcers, venous ulcers, pressure ulcers, burns, and other dermal ulcerations. The amniotic membrane’s therapeutic potential includes anti-inflammatory effects, reduced scarring, and enhanced epithelization. Studies indicate a high treatment efficacy, with 86% to 90% success rates in chronic wound healing​​.
Growth Factors and Proteins:
-
Growth factors: EGF, bFGF, KGF, PDGF, VEGF, TGF-beta 1 and -beta 3, HGF, TIMP/MMP, NGAL.
-
Proteins: Collagen I, III, IV, V, and VII, Elastin, Fibronectin, Laminin.
Meet Our Medical Directors
At WoundCareRus, our dedicated team of professionals is committed to providing exceptional wound care and healing solutions. Led by experts in the field, we combine cutting-edge technology with compassionate care to address a wide range of wound management needs. Our team includes skilled clinicians, experienced nurses, and knowledgeable support staff, all working together to ensure optimal patient outcomes and enhance quality of life. Trust WoundCareRus to deliver personalized and effective care every step of the way.
FLORIDA LOCATION
Medical Director
DNP, FNP-BC
Dr. Ventricia Harris-Victor is a distinguished Family Nurse Practitioner with a Doctor of Nursing Practice (DNP) degree. Board-certified in Family Practice (FNP-BC), she brings extensive clinical expertise and a commitment to patient-centered care. Dr. Harris-Victor is dedicated to advancing healthcare through both practice and education, combining her clinical acumen with a passion for improving community health outcomes.
Medical Director
Lagny P. Victor
MD
Dr. Lagny P. Victor is a highly respected physician known for his expertise and dedication. Dr. Victor is committed to providing exceptional patient care and advancing medical knowledge. His approach combines evidence-based practices with compassionate care, ensuring each patient receives personalized and effective treatment. Dr. Victor’s commitment to excellence extends beyond the clinic, as he actively contributes to the medical community through research and education.
